TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›AFCG
AFCG logo

AFCG

Advanced Flower Capital Inc.

Next earnings Aug 12, 2026 · consensus $0.13 EPS, $7.00M rev

Last earnings +11.6% on 2026-05-07

Hold
$3.13
▼ -3.40%
$3.13▼ -28.17%
over 1Y
L $2.05H $4.75
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-3.4%
1W-1.3%
1M-16.1%
3M+11.4%
YTD+11.9%
1Y-28.2%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
D
Valuation
Fair value
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy

Cannabis lender trading at ~0.4x book, but a collapsing loan book and first annual loss make it a deep-value trap, not a bargain.

Revenue $24.6M · FY2025

AFC is a specialty cannabis lender that just elected BDC status effective Jan 1, 2026 — a fresh regulatory regime the 10-K itself flags via 'limited operating history as a BDC.' The numbers describe a business in retreat: revenue has fallen four straight years (74.7M → 63.9M → 45.7M → 24.6M), with FY2025 down 46.2% YoY, and the July-2024 SUNS spin-off stripped out the CRE portfolio, shrinking the remaining engine. FY2025 flipped to a -20.7M net loss (net margin -84.2%, ROE -11.8%) after two years of solid profit, and cash was cut 62.7% to 38.6M while accumulated deficit deepened to -83.4M. This is not a soft patch — it is credit deterioration showing up in the P&L.

The MD&A makes the cause concrete: Private Company K was placed in consensual receivership in Jan 2025, AFC initiated mortgage foreclosure against Subsidiary of Private Company G over a cultivation facility (citing a lost cannabis license and payment defaults), and by April 2025 was suing guarantors. The Risk Factors underscore that the portfolio is 'concentrated in a limited number of loans,' so a single distressed borrower moves the whole book — exactly what the loss reflects. Cannabis-specific risk (federal enforcement, borrower license loss, illiquid collateral) compounds the concentration.

Is AFCG a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~3.13
  • Short call 3.5 @ ~0.12 est
debit $301max +$49max −$300BE 3.01

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—$74.7M$63.9M$45.7M$24.6M
Gross profit—————
Operating income—————
Net income——$21.0M$16.8M-$20.7M
Diluted EPS$1.52$1.79$1.02$0.78-$0.95
Net margin——32.8%36.8%-84.2%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-29.0%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash$38.6M
Piotroski F-Score2/6

Capital returns

Buyback yield—
Dividend yield (est.)58.3%
Shareholder yield58.3%
Shares Δ YoY+4.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Material agreement2026-06-30

    Entered new material loan/credit agreement, adding a direct debt obligation

  2. 8-K Reg FD disclosure2026-06-18

    Reg FD disclosure (Item 7.01) — investor update/presentation

  3. 8-K Shareholder vote2026-05-28

    Disclosed shareholder meeting voting results

  4. 8-K Earnings results2026-05-07

    Q1'26: revenue decline continues as BDC conversion takes hold

  5. 10-Q Quarterly report2026-05-07

    Q1'26: revenue decline continues as BDC conversion takes hold

  6. DEF 14A Proxy statement2026-04-17

    Annual meeting proxy — routine board/governance items

  7. 8-K Material agreement2026-03-30

    Entered material agreement creating a new financing obligation

  8. 8-K Earnings results2026-03-04

    FY25: revenue -46%, -$20.7M loss, elected BDC status Jan 2026

  9. 10-K Annual report2026-03-04

    FY25: revenue -46%, -$20.7M loss, elected BDC status Jan 2026

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-262026-06-30open ↗8-KPeriod ending 2026-06-172026-06-18open ↗SCHEDULE 13D/AFiling2026-06-18open ↗8-KPeriod ending 2026-05-282026-05-28open ↗4Period ending 2026-05-142026-05-19open ↗SCHEDULE 13G/AFiling2026-05-15open ↗8-KPeriod ending 2026-05-072026-05-07open ↗10-QPeriod ending 2026-03-312026-05-07open ↗SCHEDULE 13G/AFiling2026-04-27open ↗ARSPeriod ending 2025-12-312026-04-17open ↗DEFA14AFiling2026-04-17open ↗DEF 14APeriod ending 2026-05-282026-04-17open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueB
GrowthF
ProfitabilityF
Financial healthC
MomentumD
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
2.0252-week4.68
Revenue
$24.6M
-46.2% YoY
Net margin
-84.2%
ROE
-11.8%
P/E
—

SEC fundamentals · FY 2025

'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$24.6M-46.2%
Net income-$20.7M-223.2%
Diluted EPS-$0.95-221.8%
Cash & equivalents$38.6M-62.7%
Total assets$276M-31.5%
Total liabilities$100M-50.2%
Stockholders' equity$176M-12.8%
L/E: 0.57x

Frequently asked

Is Advanced Flower Capital Inc. (AFCG) a buy?
AFCG currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Cannabis lender trading at ~0.4x book, but a collapsing loan book and first annual loss make it a deep-value trap, not a bargain.
What is Advanced Flower Capital Inc.'s quality score?
AFCG scores 40.847972145699416/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001822523, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 7/3/2026, 4:40:49 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 12:40 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 1 open-market buy · 0 sales

2026-05-14
TANNENBAUM LEONARD M
Director
Buy90.6K @ $2.84$257K
2026-03-31
Tannenbaum Robyn
President and CIO
Buy7.00K @ $2.80$19.6K
2026-03-31
TANNENBAUM LEONARD M
Director
Buy29.0K @ $2.76$80.2K
2026-03-27
TANNENBAUM LEONARD M
Director
Buy4.30K @ $2.60$11.2K
2026-03-26
TANNENBAUM LEONARD M
Director
Buy19.7K @ $2.60$51.3K
2026-03-24
TANNENBAUM LEONARD M
Director
Buy44.9K @ $2.59$116K
2026-03-23
TANNENBAUM LEONARD M
Director
Buy14.4K @ $2.59$37.2K
2026-03-20
TANNENBAUM LEONARD M
Director
Buy115K @ $2.55$294K
2026-03-19
TANNENBAUM LEONARD M
Director
Buy60.6K @ $2.59$157K
2026-03-18
TANNENBAUM LEONARD M
Director
Buy90.6K @ $2.59$235K
2026-03-16
TANNENBAUM LEONARD M
Director
Buy34.3K @ $2.59$88.8K
2026-03-13
TANNENBAUM LEONARD M
Director
Buy15.0K @ $2.60$39.0K

Dividends

Semi-annual
Yield (TTM)
8.0%
Annual / share
$0.25
Last ex-date
2026-06-30
Last amount
$0.05
ex 2026-06-30paid 2026-07-15$0.05
ex 2026-03-31paid 2026-04-15$0.05
ex 2025-09-30paid 2025-10-15$0.15
ex 2025-06-30paid 2025-07-15$0.15
ex 2025-03-31paid 2025-04-15$0.23
ex 2024-12-31paid 2025-01-15$0.33

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-07Beat +32.8% est▲ +10.24%8-K ↗
2026-03-04Miss -541.2% est▲ +14.91%8-K ↗
2025-11-12Miss -21.6% est▲ +0.32%8-K ↗
2025-08-14Miss -36.9% est▼ -1.57%8-K ↗
2025-05-14—▼ -8.85%8-K ↗
2025-03-13—▼ -21.28%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score41 vs 67
Revenue growth-46.2% vs 7.5%
Net margin-84.2% vs 10.0%
Return on equity-11.8% vs 12.0%
P/E— vs 26.2